Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

MDT delivers strong earnings in the fiscal 2025 third quarter, with significant improvements in both gross and operating ...

Today, Benzinga's options scanner identified 8 options transactions for DexCom. This is an unusual occurrence. The sentiment ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period. DexCom develops continuous glucose monitoring (CGM) devices that help ...

In terms of liquidity and interest, the mean open interest for Medtronic options trades today is 942.55 with a total volume of 26,313.00.

Medtronic stock skidded Tuesday after the medtech giant missed sales expectations, though profit came in well ahead of forecasts.

The Federal Communications Commission on Wednesday released the transcript of a “60 Minutes” interview with Vice President Kamala Harris that has been at the center of a lawsuit between CBS and ...

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks Consensus Estimate for quarterly revenues in the to-be-reported quarter is ...

Over the past decade, the rising cost of insulin epitomized the broader systemic issue of higher healthcare out-of-pocket ...

Given the complexity of the American healthcare system, there’s no magic bullet when it comes to reducing insulin prices—or any ... within the same coverage year that Medicare enrollees ...

“Insulin used to cost around $500 for one box, and now it’s down to somewhere around $150, $200, so they’ve really dropped ...

Insulin prices rose by around 184% in a decade from 2012 to 2021, according to the Health Care Cost Institute. A 30-day supply of insulin cost around $499 in 2021, before the Inflation Reduction Act ...